Click on headlines below to download research

Positive data in high-risk patients
Paion | 27/03/2017

Paion has taken an important step towards its goal of US approval for its ultra-fast-acting sedative, remimazolam with the announcement of positive top…

Executive Interview - IQE
Executive Interview - IQE | 27/03/2017

IQE’s specialist compound semiconductor material is used in a wide variety of electronic components where silicon is not able to provide adequate…

Emerging opportunities
Raven Russia | 27/03/2017

Management’s outlook is cautiously optimistic and market conditions have improved since the start of 2016. Raven’s FY16 results show an IFRS…

FY17 trading broadly in line
Solid State | 27/03/2017

Solid State has announced that FY17 trading is likely to be broadly in line with market expectations, with delays in antenna projects in Q4 pushing performance…

Surfing the next wave of biosimilars
Formycon | 27/03/2017

Formycon is a pure-play biosimilar company focused on third-wave biosimilars (those coming off patent after 2020), an overlooked opportunity for most biosimilar…